Joshua H. Bilenker, President & CEO at Loxo Oncology, Inc. (LOXO), sold 30,200 shares at $164.16 ($5.0M) on 2018-09-12, disclosed to the SEC on 2018-09-14.
Open-market sale of $5.0M LOXO by President & CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $164.16 | 700 | $115K | 2.3% |
| 2 | $165.18 | 3,700 | $611K | 12.2% |
| 3 | $166.49 | 2,400 | $400K | 8.0% |
| 4 | $167.38 | 1,800 | $301K | 6.0% |
| 5 | $168.51 | 800 | $135K | 2.7% |
| 6 | $169.89 | 200 |
| $34K |
| 0.7% |
| 7 | $169.89 | 200 | $34K | 0.7% |
| 8 | $171.07 | 400 | $68K | 1.4% |
| 9 | $165.43 | 5,636 | $932K | 18.6% |
| 10 | $165.43 | 5,636 | $932K | 18.6% |
| 11 | $166.52 | 3,402 | $567K | 11.3% |
| 12 | $166.52 | 3,402 | $567K | 11.3% |
| 13 | $167.32 | 962 | $161K | 3.2% |
| 14 | $167.32 | 962 | $161K | 3.2% |
| Total | $166.15 avg | 30,200 | $5.0M | 100% |
| Filing → |
| LOXO | SELL | 2018-11-28 | $2.9M | — | Filing → |
| LOXO | SELL | 2018-10-05 | $5.4M | — | Filing → |
| LOXO | SELL | 2018-08-15 | $4.6M | — | Filing → |